Maynard Um
-
-
-
-
-
-
-
Agios Pharma (AGIO) Tops Q1 EPS by 12c
-
-
-
-
-
-
-
Truist Securities stays Buy on Agios Pharma (AGIO) as co seeks accelerated approval for mitapivat
-
-
-
-
-
-
-
Agios Pharma (AGIO) PT Raised to $34 at BofA Securities
-
-
-
-
-
-
-
Truist Securities Starts Agios Pharma (AGIO) at Buy
-
-
-
-
-
-
-
Agios Pharma (AGIO) Tops Q3 EPS by 12c
-
-
-
-
-
-
-
Goldman Sachs on Agios Pharma (AGIO): 'we see a favorable risk-benefit profile'
-
-
-
-
-
-
-
Agios addresses analyst report on PYRUKYND safety data
-
422,709 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

